By Monica Heger
This story was originally posted March 9.
Sequenom is on track to launch its sequencing-based prenatal diagnostic test for trisomy 21, called SensiGene T21, as a laboratory-developed test by the end of 2011 or early 2012 and plans to file for premarket approval of the test with the US Food and Drug Administration by late 2012 or early 2013.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.